ETF - 美股 | etnet 經濟通|香港新聞財經資訊和生活平台

25,565.74

-87.23

(-0.34%)

25,533

-65

(-0.25%)

低水33

8,490.31

-43.53

(-0.51%)

4,620.29

-5.86

(-0.13%)

2,335.15億

3,956.57

+44.05

(+1.126%)

4,630.28

+39.49

(+0.860%)

14,048.88

+207.55

(+1.499%)

2,740.42

+13.56

(+0.50%)

79,523.0300

+499.2800

(0.632%)

人民幣最佳客戶買入價

1.1700

澳元最佳客戶買入價

5.6392

歐元最佳客戶買入價

9.1489

英鎊最佳客戶買入價

10.6626

日圓最佳客戶買入價

4.9302

／

i

按可檢視更多數據

代號	名稱	貨幣	按盤價	今日升跌	成交金額	市值	1分鐘圖
RSST	Return Stacked U.S. Stocks & Managed Futures ETF	USD	33.430	0.505%	2.11百萬	5.05億
RSSX	Return Stacked U.S. Stocks & Gold/Bitcoin ETF	USD	28.360 盤前29.090	-1.253% +2.574%	25.54萬 8,727.00	7.47千萬
RSSY	Return Stacked U.S. Stocks & Futures Yield ETF	USD	25.620	0.314%	41.09萬	9.39千萬
RSIT	Return Stacked International Stocks & Managed Futures ETF	USD	21.250	0.047%	18.68萬	6.96千萬
RSSB	Return Stacked Global Stocks & Bonds ETF	USD	31.250	-0.143%	1.79百萬	5.27億
RSBA	Return Stacked Bonds & Merger Arbitrage ETF	USD	20.547	-0.160%	25.40萬	5.25千萬
RSBT	Return Stacked Bonds & Managed Futures ETF	USD	18.930	0.451%	11.62萬	1.47億
RSBY	Return Stacked Bonds & Futures Yield ETF	USD	18.000	-0.067%	5.39萬	5.54千萬
HAUS	Residential REIT ETF	USD	18.669	-0.633%	8,830.51	8.08百萬
NIXT	Research Affiliates Deletions ETF	USD	34.829	0.156%	1.26萬	4.31千萬
IPOS	Renaissance International IPO ETF	USD	23.660	0.019%	7.99萬	1.18千萬
IPO	Renaissance IPO ETF	USD	54.220 盤前54.220	0.018% 0.000%	40.53萬 18.22	1.52億
RSMV	Relative Strength Managed Volatility Strategy ETF	USD	29.188	-0.093%	12.09萬	2.13千萬
MBSF	Regan Floating Rate MBS ETF	USD	25.730	0.058%	82.51萬	2.46億
MBSX	Regan Fixed Rate MBS ETF	USD	27.499	-0.131%	2,290.81	2.00千萬
RAAR	Reckoner Yield Enhanced AAA CLO Reinvesting ETF	USD	51.235	0.039%	8,584.49	1.28千萬
RAAA	Reckoner Yield Enhanced AAA CLO ETF	USD	25.065	0.040%	3,263.45	3.51千萬
RAAY	Reckoner Yield Enhanced AAA CLO Annual ETF 創52周高	USD	102.525	0.034%	717.03	1.54千萬
RCLR	Reckoner BBB-B CLO Reinvesting ETF	USD	51.500	-0.097%	619.43	1.55千萬
RCLO	Reckoner BBB-B CLO ETF	USD	25.125	-0.099%	7.30萬	4.53千萬

最新

人氣

etnet TV

財經新聞

評論

專題透視

生活

DIVA

健康好人生

香港好去處